Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury.
about
Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathwayCytochrome P450 eicosanoids in hypertension and renal diseaseVascular actions of 20-HETEOpposite effects of gene deficiency and pharmacological inhibition of soluble epoxide hydrolase on cardiac fibrosisOral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin patternRenal Ischemia/Reperfusion Injury in Soluble Epoxide Hydrolase-Deficient MiceTanshinone IIA pretreatment attenuates ischemia/reperfusion-induced renal injuryVascular characterization of mice with endothelial expression of cytochrome P450 4F2.Role of TRPV1 channels in ischemia/reperfusion-induced acute kidney injury.High temporal resolution parametric MRI monitoring of the initial ischemia/reperfusion phase in experimental acute kidney injury.A p38MAPK/MK2 signaling pathway leading to redox stress, cell death and ischemia/reperfusion injury.Renal oxygenation in acute renal ischemia-reperfusion injury.20-HETE in acute kidney injury.The circadian clock modulates renal sodium handling.Deficiency in the Formation of 20-Hydroxyeicosatetraenoic Acid Enhances Renal Ischemia-Reperfusion InjuryOmega-3 fatty acid supplementation and cardiovascular disease.Role of medullary blood flow in the pathogenesis of renal ischemia-reperfusion injury.Molecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic TargetTransient receptor potential vanilloid 1 (TRPV1), TRPV4, and the kidney.Linking non-invasive parametric MRI with invasive physiological measurements (MR-PHYSIOL): towards a hybrid and integrated approach for investigation of acute kidney injury in rats.Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury.How bold is blood oxygenation level-dependent (BOLD) magnetic resonance imaging of the kidney? Opportunities, challenges and future directions.Effect of Cytochrome P450 Metabolites of Arachidonic Acid in Nephrology.The cardioprotection of dihydrotanshinone I against myocardial ischemia-reperfusion injury via inhibition of arachidonic acid ω-hydroxylase.Chemical synthesis and biological evaluation of ω-hydroxy polyunsaturated fatty acids.Liver Graft Susceptibility during Static Cold Storage and Dynamic Machine Perfusion: DCD versus Fatty Livers.A Randomized Trial of Effects of Alcohol on Cytochrome P450 Eicosanoids, Mediators of Inflammation Resolution, and Blood Pressure in Men.Low dose nitrite improves reoxygenation following renal ischemia in rats.Magnetic Resonance Imaging (MRI) Analysis of Ischemia/Reperfusion in Experimental Acute Renal Injury.
P2860
Q28235974-92D0A88C-D89C-4841-A725-59ABA23A3991Q28252210-95FF7492-922C-48F5-8CD2-2DFA2564AF11Q28259468-29973A6A-9D1E-48F8-82BF-B8634D106D16Q28383719-B82BBB69-E8EB-4FC3-B65B-E05A6C619344Q28397238-4F19CD73-10E4-4E53-80B1-86403597937BQ28398028-2C1F6F41-C81C-4E3A-9B46-2326CE6A4BF1Q28828865-0DADD84B-1C32-472C-A362-48798BC8EC27Q33775129-E17EB41C-FA81-4E8C-82DD-016BE1713ADEQ34361800-AF6F5F86-9F30-40E7-A4F6-C16BBEABC388Q34612094-592B86BF-C360-460B-BA4C-613318B372BAQ35085128-37F84E6E-B0EA-4E6A-81C0-BABDC67AAA49Q35112037-4FE6101E-E3FF-4302-A63C-D4DFE4B1D37EQ35135211-A6C3C905-C19B-4174-BA51-9238E6897FC2Q35982363-5B135698-DA57-423B-ACCE-9E7ED49C59C4Q36104856-EC36A862-AA86-454B-8AC7-F73B2B70855BQ36387184-FFF7FE6E-A609-4CAD-86A2-157FDB7AD805Q36728865-2DC2AFF0-BE75-4088-AE06-16637C66C613Q37340856-084FCF28-81D2-4826-A533-E98076DF727BQ37731230-AD3C2B3F-88AE-45B3-B554-4C804EC62207Q38068579-6B537037-3C67-4877-9EA6-AE0CE61CF101Q38075585-C2E61274-A4AB-42C7-B245-61AD1E00827CQ38083851-41F78161-7E25-47D8-8EA5-907EF435627DQ38247565-59BFB5AC-DE0A-4E0D-87FE-7767E2C054A1Q39431317-D22A0D23-CAB6-42C5-BBBD-9FFE32305BA9Q39435842-F23F6736-51B5-481F-B489-4A58B6AF6F7FQ43965598-7B2D87D2-AC72-4D10-BB7C-9380EF4F202CQ47172365-81F510B1-7921-43F0-AB0A-4EB610D4A5F1Q47947231-17412945-5EEB-48B2-AB0E-CBA14C209397Q49966137-40D8D085-AE82-490A-B8DB-6106AFCBF320Q52859646-EE904E32-002D-4CB2-B1AE-3E19040A3DBD
P2860
Inhibition of 20-HETE synthesis and action protects the kidney from ischemia/reperfusion injury.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Inhibition of 20-HETE synthesi ...... m ischemia/reperfusion injury.
@en
Inhibition of 20-HETE synthesi ...... m ischemia/reperfusion injury.
@nl
type
label
Inhibition of 20-HETE synthesi ...... m ischemia/reperfusion injury.
@en
Inhibition of 20-HETE synthesi ...... m ischemia/reperfusion injury.
@nl
prefLabel
Inhibition of 20-HETE synthesi ...... m ischemia/reperfusion injury.
@en
Inhibition of 20-HETE synthesi ...... m ischemia/reperfusion injury.
@nl
P2093
P2860
P50
P356
P1433
P1476
Inhibition of 20-HETE synthesi ...... m ischemia/reperfusion injury.
@en
P2093
Bert Flemming
Cosima Arnold
Duska Dragun
Erdmann Seeliger
Ivo Lukitsch
Lyubov Chaykovska
Mechthild Ladwig
T Florian Fuller
Vijay L Manthati
P2860
P2888
P356
10.1038/KI.2010.377
P407
P577
2010-10-20T00:00:00Z